- Home
- CRDF vs BNY Comparison
CRDF vs BNY Comparison
Compare CRDF & BNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRDF
- BNY
- Stock Information
- Founded
- CRDF 1999
- BNY 2001
- Country
- CRDF United States
- BNY United States
- Employees
- CRDF N/A
- BNY N/A
- Industry
- CRDF Biotechnology: Biological Products (No Diagnostic Substances)
- BNY Trusts Except Educational Religious and Charitable
- Sector
- CRDF Health Care
- BNY Finance
- Exchange
- CRDF Nasdaq
- BNY Nasdaq
- Market Cap
- CRDF 288.7M
- BNY 246.8M
- IPO Year
- CRDF N/A
- BNY N/A
- Fundamental
- Price
- CRDF $4.75
- BNY $10.51
- Analyst Decision
- CRDF Strong Buy
- BNY
- Analyst Count
- CRDF 3
- BNY 0
- Target Price
- CRDF $10.33
- BNY N/A
- AVG Volume (30 Days)
- CRDF 971.7K
- BNY 52.7K
- Earning Date
- CRDF 02-27-2025
- BNY 01-01-0001
- Dividend Yield
- CRDF N/A
- BNY 3.93%
- EPS Growth
- CRDF N/A
- BNY N/A
- EPS
- CRDF N/A
- BNY N/A
- Revenue
- CRDF $688,000.00
- BNY N/A
- Revenue This Year
- CRDF $25.03
- BNY N/A
- Revenue Next Year
- CRDF N/A
- BNY N/A
- P/E Ratio
- CRDF N/A
- BNY N/A
- Revenue Growth
- CRDF 49.57
- BNY N/A
- 52 Week Low
- CRDF $1.65
- BNY $8.60
- 52 Week High
- CRDF $6.42
- BNY $10.80
- Technical
- Relative Strength Index (RSI)
- CRDF 62.77
- BNY 57.23
- Support Level
- CRDF $4.12
- BNY $10.37
- Resistance Level
- CRDF $4.38
- BNY $10.54
- Average True Range (ATR)
- CRDF 0.38
- BNY 0.08
- MACD
- CRDF 0.04
- BNY 0.01
- Stochastic Oscillator
- CRDF 80.17
- BNY 53.57
About CRDF Cardiff Oncology Inc.
Cardiff Oncology Inc a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies across a range of cancers with the greatest unmet medical need. It is focusing on clinical program in indications such as RAS-mutated metastatic colorectal cancer ("mCRC"), as well as in investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma ("mPDAC"), small cell lung cancer ("SCLC"), and triple negative breast cancer ("TNBC").
About BNY BlackRock New York Municipal Income Trust
Blackrock NY Municipal Income Tr investment objective is to provide shareholders with as high a level of current income exempt from U.S. federal income taxes and New York State and New York City personal income taxes as is consistent with its investment policies and prudent investment management.